Marshall Financial Group (Maryland)’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
2,008
-42
-2% -$19.4K 0.16% 123
2026
Q1
$984K Buy
2,050
+44
+2% +$22.5K 0.16% 117
2025
Q4
$1.13M Sell
2,006
-1,108
-36% -$629K 0.22% 103
2025
Q3
$1.6M Buy
3,114
+44
+1% +$19.2K 0.31% 76
2025
Q2
$979K Buy
3,070
+135
+5% +$40.5K 0.19% 127
2025
Q1
$894K Buy
2,935
+354
+14% +$119K 0.2% 127
2024
Q4
$857K Buy
+2,581
New +$875K 0.21% 126

Other funds holding MEDP

Marshall Financial Group (Maryland)'s MEDP Position: Q2 2026 in Review

Marshall Financial Group (Maryland) reduced its Medpace (MEDP) stake by 2% in Q2 2026, selling an estimated $19.4K and leaving 2,008 shares worth $1.06M. The position accounts for 0.16% of the portfolio, ranked #123.

Marshall Financial Group (Maryland) first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.6M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Marshall Financial Group (Maryland) held 2,008 shares of Medpace worth $1.06M as of Q2 2026.
  • Marshall Financial Group (Maryland) sold 42 Medpace shares in Q2 2026, an estimated $19.4K.
  • Medpace made up 0.16% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #123 holding.
  • Marshall Financial Group (Maryland) first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Marshall Financial Group (Maryland)'s Medpace position peaked at $1.6M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.